FRLI (FRLI) Stock Price & Analysis
FRLI (FRLI) rose 0.00% to USD 0 as of July 26, 2026 at 05:55 UTC, according to Nexqual real-time market data.
FRLI last closed at USD 0; the session ranged USD 0–0 on volume of 7,603 shares. Market capitalization is $5,346, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, July 26, 2026 at 05:55 UTC.
Key Statistics (as of July 26, 2026 at 05:55 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 7,603 shares |
| Market Cap | $5,346 |
| Exchange | PNK |
Technical Analysis (FRLI)
Nexqual's technical model rates FRLI "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 05:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (FRLI)
Wall Street analysts rate FRLI "None", per Nexqual as of July 26, 2026 at 05:55 UTC.
| Consensus Rating | None |
|---|
Earnings (FRLI)
Source: Nexqual, July 26, 2026 at 05:55 UTC.
Financials & Fundamentals (FRLI)
| Total Revenue | $81,955 |
|---|---|
| Revenue Growth (YoY) | +76.30% |
| Gross Margin | +74.03% |
| Operating Margin | -10514.01% |
| Profit Margin | +0.00% |
| ROE | -671.62% |
| Debt / Equity | 17.62 |
| Current Ratio | 0.24 |
| Total Cash | $12,155 |
| Total Debt | $202,547 |
| Free Cash Flow | $261,332 |
Source: Nexqual, July 26, 2026 at 05:55 UTC.
Financial Health Score (FRLI)
Nexqual rates FRLI's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 05:55 UTC.
| Growth | Strong — Revenue +76% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $12K cash, no debt |
| Cash Flow | Strong — FCF $261K, 319% margin |
| Efficiency | Critical — ROE -672%, ROA -273.9% |
Ownership (FRLI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 53.47M |
| Float | 0 |
Source: Nexqual, July 26, 2026 at 05:55 UTC.
Leadership (FRLI)
FRLI is led by Ian Geran Jenkins (age 41), President, CEO, CFO & Director, per Nexqual as of July 26, 2026 at 05:55 UTC.
| President, CEO, CFO & Director | Ian Geran Jenkins (age 41) |
|---|---|
| CTO & Director | Jayson Uffens (age 49) |
| Chief Marketing Officer | Seth Charles Jones (age 36) |
| Chief Medical Officer & Director | Hans Jenkins (age 48) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHMJF | CHEMISTREE TECHNOLOGY INC | USD 0.02 | ▲ 0% |
| VICA | Rafina Innovations Inc. | USD 0 | ▲ 0% |
| DTRK | DATATRAK International, Inc. | USD 0.28 | ▲ 64.71% |
| BEAG | Bold Eagle Acquisition Corp. | USD 10.67 | ▼ 0.08% |
| PKTX | ProtoKinetix, Inc. | USD 0.01 | ▲ 3.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 05:55 UTC. This page is informational and not investment advice.